Barricade Coil System 900011Recalls & reported problems
Balt USA LLC · Barricade Coil System (BCS) is intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The BCS is also intended for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolizations in the peripheral vasculature. The BCS consists of an implantable coil attached to a delivery pusher. The delivery pusher is powered by the Blockade Detachment Controller (BDC) designed specifically for the BCS. The device comes pre-loaded with one 9-volt battery. A BlockWire Connecting Cable or Handheld Detachment Cable, comprised of a red and black cable leads are required to detach Barricade Detachable Coils and must be used in conjunction with a return electrode. · Class 2 · Implant
All models of Barricade Coil System (18)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00818053020124), received between May 8, 2018 and May 23, 2018 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Off-Label Use” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Off-Label Use1
- Premature Activation1
Patient problems
- Aneurysm2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMay 23, 2018Off-Label Use; Off-Label Use
IT WAS REPORTED THAT WHILE TREATMENT OF AN ANEURYSM LOCATED AT MCA. "THE TIP OF MC (ECHELON 10) WAS PLACED AT MIDDLE OF THE ANEURYSM AND THE COIL WAS PUSH-OUT FROM THE CATHETER. HOWEVER, THE FIRST LOOP CAME OFF FROM THE ANEURYSM, AND MICROCATHETER KICKED-BACK TO MAIN VESSEL DURING WITHDRAWAL OF THE COIL. THEN, THE SURGEON RE-INSERTED THE MICROCATHETER INTO THE ANEURYSM DEEPER THAN FIRST ATTEMPT AND TRIED TO PUSH-OUT THE COIL INTO THE ANEURYSM. WHEN ABOUT 90% OF THE TOTAL LENGTH WAS PLACED, ONE OF THE LOOP WAS CAME OFF OUT OF THE ANEURYSM AND THEN IT WAS CONFIRMED THAT THE PERFORATION WAS OCCURRED. THE SURGEON PERFORMED REVERSING OF HEPARIN AND INFLATING THE BALLOON FOR THE TREATMENT FOR THE PERFORATION. FOUR MINUTES PASSED, THE SURGEON DEFLATED THE BALLOON AND PERFORMED CONTRASTRADIOGRAPHY, IT WAS CONFIRMED THAT THE BLEEDING WAS STOPPED. FINALLY, THE COIL HAD DETACHED PROPERLY AT REVERSE "T" POSITION. THE PROCEDURE WAS COMPLETED SINCE THERE WAS NO PROBLEM FOR THE PATIENT'S SITUATION (CONSCIOUSNESS, SPEECH, VISUAL FIELD ETC.)" SURGEON'S COMMENTS: HE COMMENTED THAT HE MISTOOK THE SELECTION OF THE COIL SIZE, HE SHOULD NOT HAVE BEEN SELECTED LONG COIL. ALSO, HE COMMENTED THAT THE TIP O
Patient problems: Aneurysm
MAUDE report 7539551 ↗MalfunctionMay 8, 2018Premature Activation; Premature Activation
IT WAS REPORTED THAT A "3MM X 10CM COMPLEX FINISH COIL WAS INSERTED INTO THE AREA OF D-AVF BY USING SL-10 BUT COIL SIZE WAS UNAPPROPRIATED AND THE SURGEON TRIED TO WITHDRAW THE COIL. HOWEVER, THE PUSHER WIRE GOT STUCK AND COULD NOT BE MOVED. THE SURGEON CUT THE PUSHER WIRE TOGETHER WITH THE HUB OF SL-10 BY SCISSORS, THEN ATTACHED THE SNARE AND PULL OUT BUT THE COIL WAS UNINTENTIONALLY DETACHED ON THE HALFWAY. THEN, THE DETACHED COIL WAS PLACED WITHIN THE PATIENT AND SL-10 WAS REMOVED."
Patient problems: Aneurysm
MAUDE report 7495737 ↗
Other Device, Neurovascular Embolization devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page